Home Tags AACR

Tag: AACR

Mersana Presents Updated Data about its Dolasynthen Platform and Synthemer Scaffold

Clinical-stage bio-pharmaceutical company, Mersana Therapeutics, presented preclinical data from the company's proprietary Dolasynthen platform and its modular Synthemer scaffold during the 2019 Annual Meeting...

How Meaningful Will Changes Be to Ethical Guidelines Following Jose Baselga’s...

In the aftermath of the fall of renowned breast cancer researcher Jose Baselga, MD, PhD, following revelations last month of his failure to disclose...

Eric Rosenthal Reports | A Personal Remembrance of Two Giants of...

James F. Holland, MD, one of the pioneers of combination chemotherapy and cancer cooperative group research, died at the age of 92 on March...

Preclinical Data Supports the Development of XMT-1536 in a Broad Population...

Update data from preclinical studies with XMT-1536, an antibody-drug conjugates or ADC being developed by Mersana Therapeutics targeting NaPi2b, were presented in a poster...

AACR 2017: Advancing Antibody-Drug Conjugate and Novel Immuno-Oncology

Multiple data presentations supporting Seattle Genetics' advancing antibody-drug conjugate or ADC and immuno-oncology programs were presented at the Annual Meeting of the American Association...

Preclinical Data on XMT-1522 Supports Efficacy and Tolerability

During the 108th Annual Meeting of the American Association for Cancer Research (AACR), held April 1 to 5, 2017, in Washington, D.C, Mersana Therapeutics,...

AACR 2017: Nine Presentations Feature ImmunoGen’s Approch to ADC development

Earlier today, ImmunoGen, a company at the forefront of antibody-drug conjugates (ADC-) development for the treatment of cancer, announced that nine abstracts highlighting the...

Phase I Trial of SGN-CD352A in Relapsed or Refractory Multiple Myeloma...

This week the first patient enrolled in a multi-center phase I clinical trial of SGN-CD352A for the treatment of patients with relapsed or refractory...

Best ADC Platform Technology Awarded to Mersana Therapeutics

This week, during the 7th World ADC Conference in San Diengo, Mersana Therapeutics, a biotechnology company focused on discovering and developing a pipeline of...

Clinical Updates Confirming Advances and Meaningful Benefits for Patients

Earlier this year, during the meetings of the American Association for Cancer Research (AACR), held April 16-20 in New Orleans, LA, and the Protein...